Showing results (71-80 of 232) with videos related to
Sort By:
Pageof 24
Journal of the National Cancer Institute|October 5, 1988
Regression models in clinical studies: determining relationships between predictors and responseF E Harrell, K L Lee, B G PollockJournal of Clinical Psychopharmacology|August 1, 1990
Clomipramine in obsessive-compulsive disorder: clinical response and plasma levelsM R Mavissakalian, B Jones, S Olson, et al.Journal of Clinical Psychopharmacology|April 1, 1989
Pemoline-induced abnormal involuntary movementsF R Sallee, R L Stiller, J M Perel, et al.Psychopharmacology Bulletin|January 1, 1993
Nortriptyline in the hospitalized elderly: tolerance and side effect reductionJ Rosen, R Sweet, B G Pollock, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|May 23, 1997
Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detectionJ P Foglia, D Sorisio, M Kirshner, et al.The American Journal of Psychiatry|May 1, 1975
Imipramine and electrocardiographic abnormalities in hyperactive childrenB G Winsberg, S Goldstein, L E Yepes, et al.Psychoneuroendocrinology|January 1, 1985
Effect of benztropine on the diurnal prolactin responses to haloperidolR S Nathan, J M Perel, T McCarthy, et al.Biological Psychiatry|June 5, 1998
Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobiaM R Mavissakalian, J M Perel, M Talbott-Green, et al.Journal of Clinical Psychopharmacology|December 1, 1987
Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?M Shostak, J M Perel, R L Stiller, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogsD L Thai, L N Yurasits, G R Rudolph, et al.Pageof 24